Target intelligence / Profile preview

Forkhead box protein C2 (FOXC2)

Target
FOXC2
Molecular classification
Transcription factor, Forkhead box (FOX) family, DNA-binding protein
01

Overview

Forkhead box protein C2 (FOXC2) is a DNA-binding transcription factor belonging to the forkhead box (FOX) family and is encoded by the *FOXC2* gene, which is intronless and encodes a 501-amino-acid protein[4][2]. FOXC2 regulates crucial developmental processes, including vascular and lymphatic development, kidney and heart formation, and differentiation of adipose tissue, as well as maintenance of glomerular basement membrane integrity[4]. It plays a pivotal role in the epithelial-mesenchymal transition (EMT), which is linked to cancer metastasis, and its mutations are causatively associated with lymphedema–distichiasis syndrome (a genetic disorder of the lymphatic system)[4][2]. FOXC2 exerts its function by directly binding to specific DNA motifs, regulating gene transcription; it is essential for the formation of pericyte-free lymphatic networks and lymphatic valves[3][1][2]. Overexpression is associated with highly metastatic cancers, especially breast cancer, and the gene is both a disease biomarker and a potential therapeutic target in cancer and lymphatic disorders[4][1][2][3].

Other names
forkhead-related protein FKHL14transcription factor FKH-14mesenchyme fork head protein 1MFH1MFH-1 proteinmesenchyme forkhead 1FKHL14LDforkhead box C2
02

Biological functions

Regulation of embryonic developmentRegulation of vascular and lymphatic developmentCell differentiation (notably in kidneys, heart, adipose tissue)Regulation of epithelial-mesenchymal transition (EMT)Regulation of gene transcription
03

Disease associations

Lymphedema–distichiasis syndromeCancer (particularly cancer metastasis, e.g. breast cancer)Varicose veinsCardiovascular and craniofacial developmental abnormalities
04

Safety considerations

Mutations in FOXC2 linked to congenital lymphedema and other developmental disordersOverexpression linked to cancer metastasisDysregulation associated with multiple organ systems (e.g., cardiovascular, lymphatic, renal)
05

Biomarkers

FOXC2 gene expression (for lymphedema–distichiasis syndrome, EMT, and certain metastatic cancers)

Beyond the preview

Go deeper on Forkhead box protein C2 (FOXC2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Forkhead box protein C2 (FOXC2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call